Literature DB >> 20488294

Clinical features, diagnosis and treatment of narcolepsy.

Imran Ahmed1, Michael Thorpy.   

Abstract

Narcolepsy is characterized by excessive daytime sleepiness, cataplexy, sleep paralysis, and hypnagogic/hypnapompic hallucinations. It is currently believed to be caused by a deficiency in hypocretin-producing neurons in the lateral hypothalamus. Diagnosis is by the presence of appropriate clinical symptoms and confirmation by a polysomnogram followed by a multiple sleep latency test. There are nonpharmacologic (eg, scheduled naps, following proper sleep hygiene) and symptom-directed pharmacologic (eg, central nervous system stimulants, modafinil, sodium oxybate, certain antidepressants) treatments that are usually used together for optimal management of narcolepsy. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20488294     DOI: 10.1016/j.ccm.2010.02.014

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  15 in total

1.  Allergies and Disease Severity in Childhood Narcolepsy: Preliminary Findings.

Authors:  Secil Aydinoz; Yu-Shu Huang; David Gozal; Clara O Inocente; Patricia Franco; Leila Kheirandish-Gozal
Journal:  Sleep       Date:  2015-12-01       Impact factor: 5.849

2.  Narcolepsy in the pediatric population.

Authors:  Erick N Viorritto; Suraiya A Kureshi; Judith A Owens
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

Review 3.  Classification of sleep disorders.

Authors:  Michael J Thorpy
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

Review 4.  Patient-Reported Measures of Narcolepsy: The Need for Better Assessment.

Authors:  Ulf Kallweit; Markus Schmidt; Claudio L Bassetti
Journal:  J Clin Sleep Med       Date:  2017-05-15       Impact factor: 4.062

5.  Narcolepsy and cataplexy: a pediatric case report.

Authors:  Tülin Savaş; Ilknur Erol; Semra Saygı; Mehmet Ali Habeşoğlu
Journal:  Turk Pediatri Ars       Date:  2016-12-01

6.  Association between pupillometric sleepiness measures and sleep latency derived by MSLT in clinically sleepy patients.

Authors:  Keiko Yamamoto; Fumio Kobayashi; Reiko Hori; Aki Arita; Ryujiro Sasanabe; Toshiaki Shiomi
Journal:  Environ Health Prev Med       Date:  2013-02-19       Impact factor: 3.674

7.  Changes in Medical Services and Drug Utilization and Associated Costs After Narcolepsy Diagnosis in the United States.

Authors:  Kathleen F Villa; Nancy L Reaven; Susan E Funk; Karen McGaughey; Jed Black
Journal:  Am Health Drug Benefits       Date:  2018-05

8.  Pupillometric assessment of sleepiness in narcolepsy.

Authors:  Bharati Prasad; Young K Choi; Terri E Weaver; David W Carley
Journal:  Front Psychiatry       Date:  2011-06-07       Impact factor: 4.157

9.  Narcolepsy type 1 features across the life span: age impact on clinical and polysomnographic phenotype.

Authors:  Althea Lividini; Fabio Pizza; Marco Filardi; Stefano Vandi; Francesca Ingravallo; Elena Antelmi; Oliviero Bruni; Filomena Irene Ilaria Cosentino; Raffaele Ferri; Biancamaria Guarnieri; Sara Marelli; Luigi Ferini-Strambi; Andrea Romigi; Enrica Bonanni; Michelangelo Maestri; Michele Terzaghi; Raffaele Manni; Giuseppe Plazzi
Journal:  J Clin Sleep Med       Date:  2021-07-01       Impact factor: 4.324

10.  Excessive daytime sleepiness assessed by the Epworth Sleepiness Scale and its association with health related quality of life: a population-based study in China.

Authors:  Shunquan Wu; Rui Wang; Xiuqiang Ma; Yanfang Zhao; Xiaoyan Yan; Jia He
Journal:  BMC Public Health       Date:  2012-10-08       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.